 Podcast - AUA 2007 - Impact Risk Factors on the Performance of a Point-of-Care Bladder Cancer Test
Tuesday, 22 May 2007
read more
|
AUA 2007 - Prostate Stem Cell Antigen as a Marker for Bladder Cancer
Tuesday, 22 May 2007
read more
|
AUA 2007 - Transurethral Detection and Resection of Bladder Carcinomas Under White or 5-ALA Induced Fluroescence Light: Results of the First Double-Blind Placebo-Controlled Clinical Trial - Bladder Cancer
Tuesday, 22 May 2007
read more
|
AUA 2007 - Differential Expression of RAL GTPASES and Their Effectors in Bladder Cancer
Tuesday, 22 May 2007
read more
|
AUA 2007 - Differential Regulation of EPHB4 and EPHB2 Receptor Tyrosine Kinases in Normal Bladder and Bladder Transitional Cell Carcinoma
Tuesday, 22 May 2007
read more
|
AUA 2007 - Transurethral Detection and Resection of Bladder Carcinomas Under White or 5-ALA Induced Fluroescence Light: Results of the First Double-Blind Placebo-Controlled Clinical Trial
Tuesday, 22 May 2007
read more
|
AUA 2007 - PD-L1 (B7-H1) Expression by Urothelial Carcinoma of the Bladder and BCG-Induced Granulomata: Associations with Localized Stage Progression
Tuesday, 22 May 2007
read more
|
AUA 2007 - Impact of Risk Factors on the Performance of a Point-of-Care Bladder Cancer Test - Poster
Monday, 21 May 2007
read more
|
AUA 2007 - NMP22 as an Adjunct to Urine Cytology and Cystoscopy in the Follow Up of Superficial TCC of Urinary Bladder - Poster
Monday, 21 May 2007
read more
|
AUA 2007 - Surgical Therapy of Urothelial Carcinomas
Sunday, 20 May 2007
read more
|
AUA 2007 - Sunday Plenary Session: The Expansion and Contraction of Urologic Practice
Sunday, 20 May 2007
read more
|
AUA 2007 - SBUR and SUO Session: How Immunology Research Drives Treatment of Bladder Cancer
Sunday, 20 May 2007
read more
|
AUA 2007 - SUO Session: Transitional Cell Carcinoma II; Are We Underutilizing Minimally Invasive Approaches for Upper Tract TCC?
Sunday, 20 May 2007
read more
|
AUA 2007 - SBUR and SUO Session: Ral GTPases and Friends: New Conspirators in Bladder Cancer Metastasis and Targets for Therapy
Sunday, 20 May 2007
read more
|
AUA 2007 - SUO Session: Transitional Cell Carcinoma I, Optimizing Outcomes at Every Stage of Bladder Cancer: Do We Practice It?
Sunday, 20 May 2007
read more
|
AUA 2007 - SUO Session: Transitional Cell Carcinoma – Optimizing Outcomes at Various Stages of Bladder Cancer
Sunday, 20 May 2007
read more
|
The Effect of Ofloxacin on Bacillus Calmette-Guerin Induced Toxicity in Patients with Superficial Bladder Cancer: Results of a Randomized, Prospective, Double-Blind, Placebo Controlled, Multicenter Study
Thursday, 17 May 2007
BERKELEY, CA (UroToday.com) - BCG immunotherapy is the current 'gold standard' for treatment of non-muscle invasive bladder cancer.
read more
|
Clinical Utility of Fluorescent in situ Hybridization for the Surveillance of Bladder Cancer Patients Treated with Bacillus Calmette-Guérin Therapy
Tuesday, 15 May 2007
BERKELEY, CA (UroToday.com) - Adjuvant intravesical therapy with BCG is commonly used to decrease the probability of recurrence and progression in patients with bladder tumors.
read more
|
The Concept of Lymph Node Density—Is it Ready for Clinical Practice
Monday, 14 May 2007
BERKELEY, CA (UroToday.com) - Lymph node density is a surrogate marker of the extent (i.e. 'quality') of lymph node dissection during radical cystectomy and impacts patient outcome.
read more
|
Matritech’s NMP22® BladderChek® Test will be Featured in Presentations at the American Urological Association (AUA) Annual Meeting
Monday, 14 May 2007
read more
|
Isothiocynate Intake Associated with a Decreased Risk of Bladder Cancer
Friday, 11 May 2007
BERKELEY, CA (UroToday.com) - Isothiocyanates (ITC) are compounds found in cruciferous vegetables such as broccoli, cauliflower, kale, turnips, collards, Brussels sprouts, cabbage, radish, turnip and watercress.
read more
|
Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness
Wednesday, 09 May 2007
BERKELEY, CA (UroToday.com) - While early cystectomy is indicated in select patients with polychronotropic stage Ta, T1, and CIS bladder cancer, the standard of care to prevent tumor progression for these patients continues to be intravesical BCG.
read more
|
Survivin Expression is Associated with Bladder Cancer Presence, Stage, Progression, and Mortality
Monday, 07 May 2007
BERKELEY, CA (UroToday.com) - Survivin is a member of the Inhibitors of Apoptosis (IAP) groups of proteins, which are known to contribute to the cell death 'escape' mechanisms of various cancer cells, including bladder cancer.
read more
|
The Modern Management of Upper Urinary Tract Urothelial Cancer: Tumour Diagnosis, Grading and Staging
Friday, 04 May 2007
Login to read more...
|
The Modern Management of Upper Tract Urothelial Cancer: Surgical Treatment
Thursday, 03 May 2007
Login to read more...
|
Podcast - Chemotherapy For High-Risk Disease At RRP
Thursday, 26 April 2007
read more
|
San Francisco Firefighters Cancer Prevention Foundation Spearheads Campaign Calling for Action to Address Firefighters Increased Risk for Cancer - Bladder Cancer Screening is the First Program Underway
Wednesday, 25 April 2007
read more
|
Matritech's NMP22(R) BladderChek(R) Test Being Used in Screening
Wednesday, 25 April 2007
read more
|
Society of Urologic Nurses and Associates Releases Guide for Nurses New to Operating Room
Tuesday, 24 April 2007
read more
|
European Urology - Histologic Grading of Noninvasive Papillary Urothelial Neoplasms
Monday, 02 April 2007
Volume 51, Issue 4, Pages 889-898 (April 2007)
Abstract -
Objectives:
In 1998, a revised system of classifying noninvasive papillary urothelial neoplasms of the urinary bladder was proposed and subsequently formally adopted by the World Health Organization (WHO).
read more
|
European Urology - Prepubic Urethrectomy during Radical Cystoprostatectomy
Monday, 02 April 2007
Volume 51, Issue 4, Pages 915-921 (April 2007)
Abstract -
Objectives:
In muscle-invasive bladder cancer, the risk of developing a urethral recurrence after cystectomy varies between 4% and 18%, especially when an ileal conduit is performed.
read more
|
European Urology - Short-Schedule Intravesical Gemcitabine with Ablative Intent in Recurrent Ta–T1, G1–G2, Low- or Intermediate-Risk, Transitional Cell Carcinoma of the Bladder
Monday, 02 April 2007
Volume 51, Issue 4, Pages 956-961 (April 2007)
Abstract -
Objectives:
Primary objective: to assess ablative efficacy and tolerability of short-schedule intravesical gemcitabine for intact, low- and intermediate-risk, recurrent superficial bladder tumours.
read more
|
European Urology - A Chemosensitivity Test for Superficial Bladder Cancer Based on Three-Dimensional Culture of Tumour Spheroids
Monday, 02 April 2007
Volume 51, Issue 4, Pages 962-970 (April 2007)
Abstract -
Objectives:
Three-dimensional (3D) spheroids are a good model for studying in vitro chemosensitivity because they reproduce unicellular and multicellular mechanisms of drug resistance.
read more
|
Implications of Statin Therapy in Bladder Cancer Patients
Thursday, 29 March 2007
BERKELEY, CA (UroToday.com) - Smoking is one of the major risk factors for the development of bladder cancer and is also associated with cardiac disease, hyperlipidemia, and atherosclerosis.
read more
|
EAU 2007 - Management of Superficial Urothelial Tumors
Thursday, 29 March 2007
read more
|
EAU 2007 - Debate - Plenary Session
Wednesday, 28 March 2007
read more
|
FDA Strengthens Safety Information for Erythropoiesis-Stimulating Agents (ESAs)
Wednesday, 14 March 2007
BERKELEY, CA (UroToday.com) - On March 9, 2007, the Food and Drug Administration issued a safety warning for all erythropoiesis-stimulating agents
read more
|
European Urology - Advanced Age Is Associated with Poorer Bladder Cancer-Specific Survival in Patients Treated with Radical Cystectomy
Wednesday, 14 March 2007
read more
|
Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay
Monday, 12 March 2007
BERKELEY, CA (UroToday.com) - "Bladder cancer continues to be a significant cause of morbidity and mortality.
read more
|
European Urology - Prognostic Markers for Bladder Cancer – Are We There Yet?
Thursday, 01 March 2007
Volume 51, Issue 3, Pages 591-592 (March 2007)
Invasive bladder cancer is a potentially lethal disease. Prognostic markers predicting outcome are clearly needed.
read more
|
RECAP FROM SE AUA PRESENTATION BY GIORA KATZ, MD
Thursday, 01 March 2007
read more
|
European Urology - Utility of Fluorescence In Situ Hybridization as a Non-invasive Technique in the Diagnosis of Upper Urinary Tract Urothelial Carcinoma
Friday, 23 February 2007
Volume 51, Issue 2, Pages 409-415 (February 2007)
Abstract -
Objectives:
To assess the clinical utility of a fluorescence in situ hybridization (FISH) assay as a non-invasive method for diagnosing and monitoring urothelial carcinoma (UC) in the upper urinary tract (UUT).
read more
|
European Urology - Synthetic Nucleic Acids as Potential Therapeutic Tools for Treatment of Bladder Carcinoma
Friday, 16 February 2007
Volume 51, Issue 2, Pages 315-327 (February 2007) Abstract - Objectives: Abnormal gene activation in human tumours including bladder cancers (bCAs) may cause altered proliferation, maturation, and apoptosis as well as development of resistance to therapeutic interventions.
read more
|
Advanced Age Is Associated with Poorer Bladder Cancer-Specific Survival in Patients Treated with Radical Cystectomy
Thursday, 15 February 2007
BERKELEY, CA (UroToday.com) - Traditional wisdom taught in urological residency has been that healthy octogenarians with bladder cancer may be offered radical cystectomy without a significantly increased incidence of postoperative complications.
read more
|
Spectrum Pharmaceuticals Announces Successful Completion of Patient Accrual in Its EOquin(R) Pilot Study, Prior to Initiating Phase 3 Studies in the U.S.
Tuesday, 13 February 2007
IRVINE, CA (Press Release) - Feb. 6 - Spectrum Pharmaceuticals (Nasdaq: SPPI) announced today that the Company has completed patient accrual in the U.S. pilot safety study of EOquin(R) in patients with noninvasive bladder cancer.
read more
|
European Urology - Perioperative Complications of Radical Cystectomy in a Contemporary Series
Tuesday, 13 February 2007
Volume 51, Issue 2, Pages 397-402 (February 2007) Abstract - Objectives: Radical cystectomy is the preferred standard treatment for patients with muscle-invasive bladder cancer. With improvements in intra- and perioperative care lower complication rates have been reported.
read more
|
European Urology - Gene Expression Analysis for the Prediction of Recurrence in Patients with Primary Ta Urothelial Cell Carcinoma
Thursday, 08 February 2007
Volume 51, Issue 2, Pages 416-423 (February 2007) Abstract - Objectives: The individual recurrence-free period after primary surgery of patients with Ta urothelial cell carcinoma (UCC) cannot be predicted accurately.
read more
|
European Urology - Advanced Age Is Associated with Poorer Bladder Cancer-Specific Survival in Patients Treated with Radical Cystectomy
Monday, 05 February 2007
Volume 51, Issue 3, Pages 699-708 (March 2007) Abstract - Objective:Bladder cancer (BCa) is a disease of older persons, the incidence of which is expected to increase as the population ages.
read more
|
European Urology -Validation of the Diagnostic Value of NMP22® BladderChek® Test as a Marker for Bladder Cancer by Photodynamic Diagnosis
Friday, 02 February 2007
Volume 51, Issue 2, Pages 403-408 (February 2007)
Abstract -
Objectives:
The aim of the present study was to validate the sensitivity and specificity of the new “point-of-care” NMP22® BladderChek® test compared to photodynamic diagnosis (PDD).
read more
|
Contribution of 11C-Choline Positron Emission Tomography/Computerized Tomography to Preoperative Staging of Advanced Transitional Cell Carcinoma
Friday, 02 February 2007
BERKELEY, CA (UroToday.com) - The SWOG neoadjuvant trial published in the New England Journal of Medicine in 2003 suggested that select patients with locally advanced bladder cancer might benefit from chemotherapy before surgery.
read more
|
Bladder Cancer 
